Janney Montgomery Scott LLC Takes $257,000 Position in Hims & Hers Health, Inc. (NYSE:HIMS)

Janney Montgomery Scott LLC acquired a new stake in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 8,708 shares of the company's stock, valued at approximately $257,000.

Other large investors also recently modified their holdings of the company. Raymond James Financial Inc. bought a new position in shares of Hims & Hers Health in the fourth quarter valued at approximately $18,048,000. O Shaughnessy Asset Management LLC bought a new position in shares of Hims & Hers Health in the fourth quarter valued at approximately $208,000. Commonwealth Equity Services LLC boosted its position in shares of Hims & Hers Health by 111.6% in the fourth quarter. Commonwealth Equity Services LLC now owns 58,894 shares of the company's stock valued at $1,424,000 after acquiring an additional 31,062 shares during the period. PNC Financial Services Group Inc. boosted its position in shares of Hims & Hers Health by 51.9% in the fourth quarter. PNC Financial Services Group Inc. now owns 17,225 shares of the company's stock valued at $417,000 after acquiring an additional 5,885 shares during the period. Finally, Amundi boosted its position in shares of Hims & Hers Health by 49.1% in the fourth quarter. Amundi now owns 12,741 shares of the company's stock valued at $328,000 after acquiring an additional 4,197 shares during the period. 63.52% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts have recently commented on HIMS shares. TD Cowen lowered shares of Hims & Hers Health from a "buy" rating to a "hold" rating and cut their price objective for the company from $44.00 to $30.00 in a research report on Tuesday, April 29th. Citigroup reiterated a "sell" rating on shares of Hims & Hers Health in a research report on Monday, June 23rd. Needham & Company LLC reiterated a "hold" rating on shares of Hims & Hers Health in a research report on Monday, June 23rd. Morgan Stanley reiterated an "equal weight" rating and set a $40.00 target price on shares of Hims & Hers Health in a research report on Wednesday, June 11th. Finally, Truist Financial set a $45.00 target price on shares of Hims & Hers Health in a research report on Tuesday, June 24th. Three analysts have rated the stock with a sell rating, eight have given a hold rating and three have given a buy rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and an average price target of $39.58.

Insiders Place Their Bets

In related news, insider Soleil Boughton sold 2,572 shares of Hims & Hers Health stock in a transaction on Monday, June 30th. The shares were sold at an average price of $50.50, for a total value of $129,886.00. Following the sale, the insider owned 160,737 shares in the company, valued at $8,117,218.50. The trade was a 1.57% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Michael Chi sold 17,102 shares of Hims & Hers Health stock in a transaction on Tuesday, June 17th. The shares were sold at an average price of $59.75, for a total transaction of $1,021,844.50. Following the completion of the sale, the insider owned 278,654 shares in the company, valued at approximately $16,649,576.50. This trade represents a 5.78% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 692,006 shares of company stock valued at $34,857,872 over the last quarter. 13.71% of the stock is owned by company insiders.

Hims & Hers Health Stock Up 1.0%

Shares of NYSE HIMS opened at $47.92 on Friday. Hims & Hers Health, Inc. has a 52 week low of $13.47 and a 52 week high of $72.98. The firm's fifty day moving average is $52.23 and its 200 day moving average is $40.28. The company has a market cap of $10.72 billion, a price-to-earnings ratio of 69.44, a PEG ratio of 1.76 and a beta of 2.02.

Hims & Hers Health (NYSE:HIMS - Get Free Report) last issued its earnings results on Monday, May 5th. The company reported $0.20 EPS for the quarter, topping the consensus estimate of $0.12 by $0.08. Hims & Hers Health had a net margin of 9.24% and a return on equity of 22.75%. The company had revenue of $586.01 million for the quarter, compared to the consensus estimate of $535.21 million. During the same period in the previous year, the firm earned $0.05 earnings per share. The firm's revenue for the quarter was up 110.7% on a year-over-year basis. Equities research analysts anticipate that Hims & Hers Health, Inc. will post 0.29 earnings per share for the current year.

About Hims & Hers Health

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.